In a study by Hansen et al [39] the OGG1 Ser326Cys polymorphism, which has a reduced glycosylase activity [40], was not associated with an increased risk of colorectal adenomas or carcinomas. The gene discussed is OGG1; the disease is colorectal adenoma.